BT-01001

N/A

Report date: 2026/04/08 15:42:16
NME

Base Information

Drug NameBT-01001
Drug Alias NameBT01001BT-01001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor inhibitorsFibroblast growth factor receptors antagonists
TargetsVascular endothelial growth factor receptorFibroblast growth factor receptors
Therapy Area/IndicationsDiabetic RetinopathyEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeyang Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeyang Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic Retinopathy
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A